Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder

NCT03829176 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03829176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
October 1, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition to disease, hereditary disease